Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progress

1 May 2025

Abstract excerpt

Vaccination remains a cornerstone in preventing infectious diseases and managing outbreaks. The COVID-19 pandemic has underscored the revolutionary impact of mRNA vaccine technology, which utilizes pathogenderived genomic sequences to generate specific antigens. This process involves in vitro transcription of mRNA, encoding target antigens that are subsequently encapsulated within lipid nanoparticles (LNPs) for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to RNA Interference and Gene Delivery
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40321006
DOI: 10.1042/ebc20253009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progressPMID 40321006Read ↗

From COVID-19 to Global Health: Challenges and Opportunities in mRNA Vaccine ProductionSemantic proximity Read ↗

Prospects and Challenges in Developing mRNA Vaccines for Infectious Diseases and Oncogenic VirusesSemantic proximity Read ↗

Recent Advances in mRNA Vaccine DevelopmentSemantic proximity Read ↗

mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious DiseasesSemantic proximity Read ↗

Enabling mRNA Therapeutics: Current Landscape and Challenges in ManufacturingSemantic proximity Read ↗

mRNA Vaccine Platforms and Lipid Nanoparticle Delivery Systems: Molecular Advances, Clinical Breakthroughs, and Regulatory Perspectives (2020–2025)Semantic proximity Read ↗

An Update on mRNA-Based Viral VaccinesSemantic proximity Read ↗

The Delivery of mRNA Vaccines for TherapeuticsSemantic proximity Read ↗

Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospectsSemantic proximity Read ↗

Current Developments and Challenges of mRNA VaccinesSemantic proximity Read ↗

Mucosal mRNA Vaccines. Merits and PerspectivesSemantic proximity Read ↗

mRNA vaccines: a new era in vaccine developmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.